重视前列腺外科包膜镶嵌增生结节的处理（“大家泌尿网”观看手术视频）

Emphasis on management of capsular embedded hyperplasia nodules

摘要

良性前列腺增生症（BPH）是老年男性最常见的疾病之一，而手术治疗是其主要的治疗方式之一。术中对于前列腺增生结节，尤其是对外科包膜镶嵌结节的处理是否妥当，与BPH术后并发症、二次手术率密切相关。本文就前列腺包膜镶嵌增生结节的来源、BPH术后并发症与包膜镶嵌增生结节的关系以及不同手术方式处理包膜镶嵌增生结节的优缺点等方面进行了归纳总结，并分享了铥激光前列腺剜除术在处理包膜镶嵌增生结节方面的经验，希望医者能在临床工作中重视对前列腺外科包膜镶嵌增生结节的处理。

Abstract

Benign prostatic hyperplasia (BPH) is one of the most common diseases in elderly men, and surgical treatment is one of the major therapeutic modalities. The management of prostatic hyperplasia nodules, especially capsular embedded hyperplasia nodules, is crucial to reduce the incidence of postoperative complications and rate of secondary surgery. In this essay, we summarize the sources of prostatic hyperplasia nodules, relationship between incidence of postoperative complications and capsular embedded hyperplasia nodules, advantages and disadvantages of various surgical procedures for the management of hyperplasia nodules and share our experience in the management of capsular embedded hyperplasia nodules in thulium laser enucleation of the prostate.

关键词

前列腺增生 / 外科包膜 / 增生结节

Key words

benign prostatic hyperplasia / surgical capsule / hyperplasia nodules

参考文献

[1] LERNER LB, MCVARY KT, BARRY MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline Part Ⅰ-initial work-up and medical management[J]. J Urol, 2021, 206(4): 806-817.

[2] GRAVAS S, GACCI M, GRATZKE C, et al. Summary paper on the 2023 European Association of Urology guidelines on the management of non-neurogenic male lower urinary tract symptoms[J]. Eur Urol, 2023, 84(2): 207-222.

[3] 魏东, 王建业, 万奔, 等. 良性前列腺增生术后再入院的原因及治疗探讨（附106例报告）[J]. 中华泌尿外科杂志, 2004, 25(3): 187-190.

[4] 李贵忠, 刘流, 黄广林, 等. 前列腺特异性抗原与前列腺结节增生病理类型的关系[J]. 中华泌尿外科杂志, 2006, 27(11): 752-754.

[5] 朱自强, 康健. 良性前列腺增生最新研究进展[J]. 临床泌尿外科杂志, 2019, 34(5): 409-412.

[6] 吴道清, 陈自谦. MRI在前列腺疾病诊断中的应用及其进展[J]. 临床放射学杂志, 2010, 29(2): 274-276.

[7] 贺琰, 王小燕, 凌冰, 等. 前列腺病变的直肠超声声像图特点及前列腺癌分期观察指标的相关性分析[J]. 中国临床新医学, 2015, 8(5): 397-403.

[8] ZHANG SJ, QIAN HN, ZHAO Y, et al. Relationship between age and prostate size[J]. Asian J Androl, 2013, 15(1): 116-120.

[9] BIERHOFF E, VOGEL J, BENZ M, et al. Stromal nodules in benign prostatic hyperplasia[J]. Eur Urol, 1996, 29(3): 345-354.

[10] XIA SJ, ZHUO J, SUN XW, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial[J]. Eur Urol, 2008, 53(2): 382-389.

[11] 黄健. 中国泌尿外科和男科疾病诊断治疗指南：2019版[M]. 北京: 科学出版社, 207-208.

[12] WOO H, LEVIN R, CANTRILL C, et al. Prospective Trial of water vapor thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in subjects with a large prostate: 6- and 12-month outcomes[J]. Eur Urol Open Sci, 2023, 58: 64-72.

[13] RASSWEILER J, TEBER D, KUNTZ R, et al. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention[J]. Eur Urol, 2006, 50(5): 969-979.

[14] CORNU JN, AHYAIS, BACHMANN A, et al. A Systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update[J]. Eur Urol, 2015, 67(6): 1066-1096.

[15] KIM A, HAK AJ, CHOI WS, et al. Comparison of long-term effect and complications between holmium laser enucleation and transurethral resection of prostate: nations-wide health insurance study[J]. Urology, 2021, 154: 300-307.

[16] MOROZOV A, TARATKIN M, SHPIKINA A, et al. Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysis[J]. World J Urol, 2023, 41(12): 3471-3483.

[17] SEAMAN EK, JACOBS BZ, BLAIVAS JG, et al. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment[J]. J Urol, 1994, 152(3): 935-937.

[18] KUO HC. Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy[J]. Urol Int, 2002, 68(2): 99-104.

[19] SEMMENS JB, WISNIEWSKI ZS, BASS AJ, et al. Trends in repeat prostatectomy after surgery for benign prostate disease: application of record linkage to healthcare outcomes[J]. BJU Int, 1999, 84(9): 972-975.

[20] ENIKEEV D, TARATKIN M, MOROZOV A, et al. Long-term outcomes of holmium laser enucleation of the prostate: a 5-year single-center experience[J]. J Endourol, 2020, 34(10): 1055-1063.

[21] ELSHAL AM, ELMANSY HM, ELHILALI MM. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH)[J]. BJU Int, 2012, 110(11 Pt C): E845-E850.

[22] TENG J, ZHANG D, LI Y, et al. Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis[J]. BJU Int, 2013, 111(2): 312-323.

[23] BHAT A, BLACHMAN-BRAUN R, HERRMANN TRW, et al. Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction[J]. World J Urol, 2022, 40(4): 889-905.

[24] LEE MS, ASSMUS MA, GUO J, et al. Relationships between holmium laser enucleation of the prostate and prostate cancer[J]. Nat Rev Urol, 2023, 20(4): 226-240.

[25] 陶凌松, 陈弋生, 孔艰, 等. 大体积前列腺增生TURP手术中前列腺包膜的意义[J]. 中国男科学杂志, 2015, 29(11): 41-44.

[26] AHYAIS A, LEHRICH K, KUNTZ RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial[J]. Eur Urol, 2007, 52(5): 1456-1463.

[27] 符伟军, 张寰, 李兴, 等. 经尿道等离子前列腺分叶剜除术的技术要点及并发症的预防（附光盘）[J]. 现代泌尿外科杂志, 2019, 24(11): 881-884.

[28] KIM TH, SONG PH. Anatomical endoscopic enucleation of the prostate for bladder outlet obstruction: a narrative review[J]. J Yeungnam Med Sci, 2022, 39(1): 12-17.

[29] SUARTZ CV, BRAZ N, DOS ANJOS GC, et al. The use of statins is related to a lower PSA level after endoscopic enucleation of the prostate with holmium laser (HoLEP) for the treatment of BPH[J]. World J Urol, 2023, 41(8): 2149-2154.

[30] 欧文, 王勇, 高庆圆, 等. 经尿道前列腺铥激光剜除术与等离子剜除术治疗前列腺增生的疗效[J]. 中国老年学杂志, 2022, 42(20): 5019-5023.

[31] 江东根, 庞俊, 肖楚天, 等. 经尿道1470 nm激光与等离子前列腺剜除术治疗良性前列腺增生症的前瞻性随机对照研究[J]. 临床泌尿外科杂志, 2017, 32(12): 908-911.

[32] TARATKIN M, KOVALENKO A, LAUKHTINA E, et al. Ex vivo study of Ho:YAG and thulium fiber lasers for soft tissue surgery: which laser for which case?[J]. Lasers Med Sci, 2022, 37(1): 149-154.

[33] 侯国栋, 朱峰, 张会清, 等. “两叶法”直出绿激光前列腺剜除术治疗良性前列腺增生的效果[J]. 河南医学研究, 2023, 32(4): 625-629.

[34] ZHUO J, WEI HB, ZHANG F, et al. Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy[J]. Asian J Androl, 2017, 19(2): 244-247.

[35] 王先进, 潘隽玮, 张祥, 等. 经尿道前列腺铥激光剜除术与绿激光剜除术治疗前列腺增生的比较研究[J]. 临床泌尿外科杂志, 2023, 38(5): 342-346.

[36] 刘世云, 杨博宇, 夏术阶, 等. 前列腺增生症外科治疗优化与并发症的关系[J]. 中华医学杂志, 2020, 100(26): 2009-2011.

[37] 周大鹏, 史有为, 曹天予, 等. “三沟两弧”铥激光前列腺剜除术治疗高龄高危大体积前列腺增生[J]. 微创泌尿外科杂志, 2023, 12(2): 102-105.